When you look at a comparison between Pricera and NR (Nicotinamide Riboside) and NMN (Nicotinamide Mononucleotide) –

Pricera comes out the clear winner!


Clinically proven to outperform both NR and NMN

Increases NAD
Simultaneously increases ATP, NAD, and GSH
Utilizes the dominant pathway for NAD synthesis
Utilizes shunt pathway for NAD synthesis
Stable in most applications
Orally bioavailable (high amounts end up in blood)
Survives digestive process intact


Supporting Documentation:

  • Avery B (Department of Pharmaceutics and Drug Delivery, The University of Mississippi), 2017. Pharmacokinetic Analysis of Plasma Nicotinamide and 1-Methyl Nicotinamide Concentrations in Toxicokinetic Study of NIAGEN (Nicotinamide Riboside).Study Report No AV151003. Unpublished Study Report, 9 pp.
  • Liu L. et al. Quantitative analysis of NAD synthesis-breakdown fluxes. CellMetab.27, 1067–1080 (2018).
  • Xue, YQ, Increasing NAD level by D-ribose and its combinations. PCT/US2019/031889 patent pending.
  • https://www.jstage.jst.go.jp/article/endocrj/advpub/0/advpub_EJ19-0313/_article
  • https://www.nature.com/articles/s41467-018-03421-7